Ardelyx (ARDX) Non Operating Income (2015 - 2026)
Ardelyx (ARDX) posted Non Operating Income of $2.1 million for Q1 2026, up 1.64% on a QoQ basis from $2.1 million in Q4 2025, and down 9.2% year-over-year from $2.3 million in Q1 2025.
Ardelyx (ARDX) Non Operating Income (2015 - 2026) Analysis & Trends
Ardelyx's Non Operating Income history runs 12 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- Quarterly Non Operating Income fell 9.2% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (down 6.88% YoY) and the FY2025 annual result came in at $8.7 million, down 4.68% from the prior year.
- Non Operating Income was $2.1 million for Q1 2026 at Ardelyx, up from $2.1 million in the prior quarter.
- Across five years, Non Operating Income topped out at $2.4 million in Q3 2025 and bottomed at $70000.0 in Q2 2022.
- A 5-year average of $1.7 million and a median of $2.1 million in 2025 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income tumbled 91.74% — and 2023, when it surged 2108.57%.
- Ardelyx's Non Operating Income stood at $375000.0 in 2022, then soared by 519.2% to $2.3 million in 2023, then grew by 3.7% to $2.4 million in 2024, then dropped by 13.7% to $2.1 million in 2025, then gained by 1.64% to $2.1 million in 2026.
- Business Quant data shows ARDX's Non Operating Income at $2.1 million in Q1 2026, $2.1 million in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.28 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 375,000.00 |
| Sep 30, 2022 | 704,000.00 |
| Jun 30, 2022 | 70,000.00 |
| Mar 31, 2022 | 484,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | -134,000.00 |
| Jun 30, 2021 | 847,000.00 |